Evidence map›Paper›PMID 28543179›Full record

ArticleThe Prostate2017

Genetic ancestry and prostate cancer susceptibility SNPs in Puerto Rican and African American men.

Margarita Irizarry-Ramírez, Rick A Kittles, Xuemei Wang, Jeannette Salgado-Montilla, Graciela M Nogueras-González, Ricardo Sánchez-Ortiz, Lourdes Guerrios, Keila Rivera, Ebony Shah, Ina Prokhorova and 3 more

Abstract read
In one paragraph

Article in The Prostate, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Genetic Ancestry Analysis Reveals Misclassification of Commonly Used Cancer Cell Lines.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2019
    Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Margarita Irizarry-RamírezDepartment of Graduate Studies, Clinical Laboratory Sciences, School of Health Professions, University of Puerto Rico, Medical Sciences Campus, San Juan, Puerto Rico.ORCID http://orcid.org/0000-0002-2177-5310
Rick A KittlesDepartment of Surgery, School of Medicine, University of Arizona, Phoenix, Arizona.
Xuemei WangDepartment of Biostatistics, University of Texas, MD Anderson Cancer Center, Houston, Texas.
Jeannette Salgado-MontillaUniversity of Puerto Rico/MD Anderson Cancer Center Partnership for Excellence in Cancer Research, University of Puerto Rico, Medical Sciences Campus, San Juan, Puerto Rico.
Graciela M Nogueras-GonzálezDepartment of Biostatistics, University of Texas, MD Anderson Cancer Center, Houston, Texas.
Ricardo Sánchez-OrtizUrology and Oncology Institute, San Juan, Puerto Rico.
Lourdes GuerriosVeterans Administration Caribbean Health Care System, Puerto Rico.
Keila RiveraDepartment of Pathology, School of Medicine, University of Puerto Rico, Medical Sciences Campus, San Juan, Puerto Rico.
Ebony ShahDepartment of Surgery, School of Medicine, University of Arizona, Phoenix, Arizona.
Ina ProkhorovaDepartment of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Pamela RobersonDepartment of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Patricia TroncosoDepartment of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Curtis A PettawayDepartment of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
The University of Texas MD Anderson Cancer Center · USUniversity of Puerto Rico, Medical Sciences Campus · PRUniversity of Arizona · USVA Caribbean Healthcare System · PR

Funding

UPR/MDACC Partnership for Excellence in Cancer Research(Parent Grant U54 CA096297)U54CA096297 · NCI · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI Ilka C Rios · 2002 to 2026
$36.9M
UPR/MDACC Partnership for Excellence in Cancer Research (Luis Segarra supplement)U54CA096300 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Larkin Strong · 2002 to 2026
$23.8M
Targeting Tumor Microenvironment-Induced Therapy Resistance in Prostate Cancer Bone MetastasisP50CA140388 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI LOGOTHETIS, CHRISTOPHER J., THOMPSON, TIMOTHY CHARLES · 2009 to 2022
$23.4M
TECHNOLOGIES AND RESOURCES FOR CORE LABORATORIESU54MD007587 · NIMHD · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI LUCIANO, CARLOS A., WOJNA, VALERIE · 2012 to 2018
$23.2M
NCI NIH HHS P50 CA140388NCI NIH HHS U54 CA096297NCI NIH HHS U54 CA096300NIMHD NIH HHS U54 MD007587
6 · The paper itself

Abstract

backgroundThe Puerto Rican (PR) population is a racially admixed population that has a high prostate cancer (PCa) mortality rate. We hypothesized in this pilot study that West African Ancestry (WAA) was associated with PCa in this heterogeneous (PR) population.

methodsA case/case and case/control study was performed. Controls, 207 African American (AA) and 133 PR were defined as men with no PCa, a serum PSA < 2.5 ng/mL and a negative rectal examination. Cases were patients with pathological specimens from radical prostatectomies (RP) (291 PR and 200 AA). DNA was extracted from whole blood of controls and from paraffin embedded normal seminal vesicle from the RPs. We assessed the association of PCa and aggressiveness with genetic ancestry using an ancestry informative marker panel (AIMs) and Wilcoxon rank-sum test and the association of PCa and aggressiveness with 15 previously PCa associated SNPs using Chi square test. Gleason Score (GS) and tumor stage (TS) were used to define low risk (GS ≤ 7[3 + 4]), TS ≤ pT2) and high risk (GS≥ 7[4 + 3], TS > pT2) PCa. Statistical analyses were done using SAS.

resultsNo difference in overall percent WAA was found between PR cases and controls. Among PR or AA cases WAA was not associated with disease severity based upon risk group, Gleason score or stage. Among AA controls WAA was significantly higher than in cases. The SNP rs7824364 (chromosome 8q24) PCa risk allele was significantly increased among cases versus controls for both AA (P < 0.0001) and PR (P = 0.0001) men. PR men with ≥1 risk allele exhibited a higher percent of WAA (39% vs 29%, P = 0.034).

conclusionThe SNP rs7824364, a local marker of WAA in the 8q24 region was associated with PCa among both AA and PR men and with increased WAA among PR men. This novel relationship of PCA risk loci, WAA with PCa and its phenotype among PR men deserves further study.

Indexed as

Prostatic NeoplasmsAgedBlack or African AmericanGenetic Association StudiesGenetic Predisposition to DiseaseHispanic or LatinoHumansMaleMiddle AgedNeoplasm GradingNeoplasm StagingPolymorphism, Single NucleotideProstateProstatectomyUnited Statescomparativehispanicunderstudied

Identifiers

PMID28543179
PMCPMC5495141
OpenAlexW2619931355

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.